|
Proprietary Name |
Dosage Form |
Strength |
NDA Applicant Name |
Date Authorized Generic Entered the Market |
Date Authorized Generic Ceased Marketing |
|
ACCUPRIL |
Tablets |
eq. 5 mg base |
Pfizer Inc. |
05/2004 - 05/2005 |
Unknown |
2 |
ACCUPRIL |
Tablets |
eq. 10 mg base |
Pfizer Inc. |
05/2004 - 05/2005 |
Unknown |
3 |
ACCUPRIL |
Tablets |
eq. 20 mg base |
Pfizer Inc. |
05/2004 - 05/2005 |
Unknown |
4 |
ACCUPRIL |
Tablets |
eq. 40 mg base |
Pfizer Inc. |
05/2004 - 05/2005 |
Unknown |
5 |
ACCURETIC |
Tablets |
eq. 10 mg base/12.5 mg |
Pfizer Inc. |
02/2005 - 02/2006 |
Unknown |
6 |
ACCURETIC |
Tablets |
eq. 20 mg base/12.5 mg |
Pfizer Inc. |
02/2005 - 02/2006 |
Unknown |
7 |
ACCURETIC |
Tablets |
eq. 20 mg base/25 mg |
Pfizer Inc. |
02/2005 - 02/2006 |
Unknown |
8 |
ACEPHEN |
Suppositories |
120 mg |
G & W Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
9 |
ACTIGALL |
Capsules |
300 mg |
Watson Laboratories, Inc. |
12/2002 - 12/2003 |
Unknown |
10 |
ADALAT CC |
Extended-release Tablets |
30 mg |
Bayer Corporation Pharmaceutical Division |
05/2000 - 04/2001 |
Unknown |
11 |
ADALAT CC |
Extended-release Tablets |
60 mg |
Bayer Corporation Pharmaceutical Division |
05/2000 - 04/2001 |
Unknown |
12 |
ADALAT CC |
Extended-release Tablets |
90 mg |
Bayer Corporation Pharmaceutical Division |
05/2000 - 04/2001 |
Unknown |
13 |
ADVIL COLD AND SINUS |
Tablets |
200 mg/30 mg |
Whitehall-Robins Healthcare |
Prior to 1/1/1999 |
Unknown |
14 |
AGRYLIN |
Capsules |
eq. 0.5 mg base |
Shire Laboratories Inc. |
4/18/2005 |
8/31/2006 |
15 |
AGRYLIN |
Capsules |
eq. 1 mg base |
Shire Laboratories Inc. |
4/19/2005 |
8/31/2006 |
16 |
ALDACTAZIDE |
Tablets |
25 mg; 25 mg |
GD Searle LLC |
01/2002 - 12/2002 |
Unknown |
17 |
ALDACTONE |
Tablets |
25 mg |
GD Searle LLC |
01/2002 |
Unknown |
18 |
ALDACTONE |
Tablets |
50 mg |
GD Searle LLC |
01/2002 |
Unknown |
19 |
ALDACTONE |
Tablets |
100 mg |
GD Searle LLC |
01/2002 |
Unknown |
20 |
ALDOMET |
Tablets |
125 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
12/1/1999 |
21 |
ALDOMET |
Tablets |
250 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
12/1/1999 |
22 |
ALDOMET |
Tablets |
500 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
12/1/1999 |
23 |
ALDORIL 15 |
Tablets |
250 mg; 15 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
24 |
ALDORIL 25 |
Tablets |
250 mg; 25 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
25 |
ALFENTA |
Injection |
eq. 0.5 mg base/mL |
Akorn, Inc. |
12/1999 - 12/2000 |
Prior to 12/2003 |
26 |
ALLEGRA |
Tablets |
30 mg |
Sanofi Aventis US LLC |
02/2005 - 02/2006 |
Unknown |
27 |
ALLEGRA |
Tablets |
60 mg |
Sanofi Aventis US LLC |
02/2005 - 02/2006 |
Unknown |
28 |
ALLEGRA |
Tablets |
180 mg |
Sanofi Aventis US LLC |
02/2005 - 02/2006 |
Unknown |
29 |
ALLEGRA-D 12 HOUR |
Extended-release Tablets |
60 mg/120 mg |
Sanofi Aventis US LLC |
12/2004 - 12/2005 |
Unknown |
30 |
ALPHAGAN |
Ophthalmic Solution |
0.2% |
Allergan Inc. |
9/6/2002 |
Unknown |
31 |
AMARYL |
Tablets |
1 mg |
Sanofi Aventis US LLC |
11/2004 - 11/2005 |
Unknown |
32 |
AMARYL |
Tablets |
2 mg |
Sanofi Aventis US LLC |
11/2004 - 11/2005 |
Unknown |
33 |
AMARYL |
Tablets |
4 mg |
Sanofi Aventis US LLC |
11/2004 - 11/2005 |
Unknown |
34 |
AMBIEN |
Tablets |
5 mg |
Sanofi Aventis US LLC |
12/2006 - 12/2007 |
Unknown |
35 |
AMBIEN |
Tablets |
10 mg |
Sanofi Aventis US LLC |
12/2006 - 12/2007 |
Unknown |
36 |
AMOXIL |
for Oral Suspension |
200 mg/5 mL |
GlaxoSmithKline |
4/2003 - 4/2004 |
Unknown |
37 |
AMOXIL |
for Oral Suspension |
400 mg/5 mL |
GlaxoSmithKline |
4/2003 - 4/2004 |
Unknown |
38 |
AMOXIL |
Tablets |
875 mg |
GlaxoSmithKline |
7/2003 - 7/2004 |
Unknown |
39 |
AMOXIL |
Tablets (chewable) |
400 mg |
GlaxoSmithKline |
4/2003 - 4/2004 |
Unknown |
40 |
ANSAID |
Tablets |
50 mg |
Pharmacia and Upjohn |
Prior to 01/1999 |
Unknown |
41 |
ANSAID |
Tablets |
100 mg |
Pharmacia and Upjohn |
Prior to 01/1999 |
Unknown |
42 |
ARAVA |
Tablets |
10 mg |
Sanofi Aventis US LLC |
9/2005 - 9/2006 |
Unknown |
43 |
ARAVA |
Tablets |
20 mg |
Sanofi Aventis US LLC |
9/2005 - 9/2006 |
Unknown |
44 |
AREDIA |
for Injection |
30 mg/vial |
Novartis |
10/2004 - 10/2005 |
Unknown |
45 |
AREDIA |
for Injection |
90 mg/vial |
Novartis |
10/2004 - 10/2005 |
Unknown |
46 |
ATIVAN |
Injection |
2 mg/mL |
Baxter Healthcare Corporation |
10/31/2003 |
Unknown |
47 |
ATIVAN |
Injection |
4 mg/mL |
Baxter Healthcare Corporation |
10/31/2003 |
Unknown |
48 |
ATIVAN |
Tablets |
0.5 mg |
Wyeth Laboratories Inc. |
Prior to 1/1/1999 |
Unknown |
49 |
ATIVAN |
Tablets |
1 mg |
Wyeth Laboratories Inc. |
Prior to 1/1/1999 |
Unknown |
50 |
ATIVAN |
Tablets |
2 mg |
Wyeth Laboratories Inc. |
Prior to 1/1/1999 |
Unknown |
51 |
ATROVENT |
Nasal Spray |
0.03% 0.021mg/spray |
Boehringer Ingelheim Pharmaceuticals Inc. |
08/2002 - 08/2003 |
Unknown |
52 |
ATROVENT |
Nasal Spray |
0.06% 0.042mg/spray |
Boehringer Ingelheim Pharmaceuticals Inc. |
08/2002 - 08/2003 |
Unknown |
53 |
AUGMENTIN |
for Oral Suspension |
200 mg/5 mL; eq, 28.5 mg base/5 mL |
GlaxoSmithKline |
06/2003 - 05/2004 |
Unknown |
54 |
AUGMENTIN |
for Oral Suspension |
400 mg/5 mL; eq. 57 mg base/5 mL |
GlaxoSmithKline |
06/2003 - 05/2004 |
Unknown |
55 |
AUGMENTIN |
Tablets |
500 mg; eq. 125 mg base |
GlaxoSmithKline |
08/2003 - 08/2004 |
Unknown |
56 |
AUGMENTIN |
Tablets |
875 mg; eq. 125 mg base |
GlaxoSmithKline |
02/2003 - 02/2004 |
Unknown |
57 |
AUGMENTIN |
Tablets (chewable) |
200 mg; eq. 28.5 mg base |
GlaxoSmithKline |
06/2003 - 05/2004 |
Unknown |
58 |
AUGMENTIN |
Tablets (chewable) |
400 mg; eq. 57 mg base |
GlaxoSmithKline |
06/2003 - 05/2004 |
Unknown |
59 |
AUGMENTIN ES-600 |
for Oral Suspension |
600 mg/5 mL; eq. 42.9 mg base/5 mL |
GlaxoSmithKline |
06/2003 - 05/2004 |
Unknown |
60 |
AVENTYL HCl |
Oral Solution |
eq. 10 mg base/5 mL |
Eli Lilly and Company |
Prior to 01/1999 |
4/25/2002 |
61 |
AZULFIDINE |
Tablets |
500 mg |
Pharmacia and Upjohn |
04/2003 - 06/2004 |
Unknown |
62 |
AZULFIDINE EN-TABS |
Delayed-release Tablets |
500 mg |
Pharmacia and Upjohn |
04/2002 - 03/2003 |
Unknown |
63 |
BENZAMYCIN |
Topical Gel |
3%; 5% |
Dermik Laboratories |
01/2003 |
Unknown |
64 |
BETAGAN |
Ophthalmic Solution |
0.50% |
Allergan, Inc. |
01/2004 - 11/2004 |
Unknown |
65 |
BETAGAN |
Ophthalmic Solution |
0.25% |
Allergan, Inc. |
Prior to 1/1/1999 |
Unknown |
66 |
BETOPTIC |
Ophthalmic Solution |
eq. 0.5% base |
Alcon Laboratories, Inc. |
9/1999 - 9/2000 |
Unknown |
67 |
BIAXIN |
for Oral Suspension |
125 mg/5 mL |
Abbott Laboratories |
12/2004 - 12/2005 |
Unknown |
68 |
BIAXIN |
for Oral Suspension |
250 mg/5 mL |
Abbott Laboratories |
12/2004 - 12/2005 |
Unknown |
69 |
BIAXIN |
Tablets |
250 mg |
Abbott Laboratories |
03/2005 |
Unknown |
70 |
BIAXIN |
Tablets |
500 mg |
Abbott Laboratories |
03/2005 |
Unknown |
71 |
BLOCADREN |
Tablets |
5 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
72 |
BLOCADREN |
Tablets |
10 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
73 |
BREVIBLOC |
Injection |
10 mg/mL |
Baxter Healthcare Corporation |
11/2002 - 10/2003 |
Unknown |
74 |
BUMEX |
Tablets |
0.5 mg |
Hoffmann-La Roche Inc. |
Prior to 1/1/1999 |
01/2001 - 12/2001 |
75 |
BUMEX |
Tablets |
1 mg |
Hoffmann-La Roche Inc. |
Prior to 1/1/1999 |
01/2001 - 12/2001 |
76 |
BUMEX |
Tablets |
2 mg |
Hoffmann-La Roche Inc. |
Prior to 1/1/1999 |
01/2001 - 12/2001 |
77 |
CALCIMAR |
Injection |
200 IU/mL |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
78 |
CAMPTOSAR |
Injection |
40 mg/2 mL |
Pharmacia and Upjohn |
06/2007 - 06/2008 |
Unknown |
79 |
CAMPTOSAR |
Injection |
100 mg/5 mL |
Pharmacia and Upjohn |
06/2007 - 06/2008 |
Unknown |
80 |
CARAFATE |
Tablets |
1 g |
Aventis Pharmaceuticals |
Prior to 1/1/1999 |
Unknown |
81 |
CARDIZEM |
Tablets |
30 mg |
Aventis Pharmaceuticals |
Prior to 1/1/1999 |
Unknown |
82 |
CARDIZEM |
Tablets |
60 mg |
Aventis Pharmaceuticals |
Prior to 1/1/1999 |
Unknown |
83 |
CARDIZEM |
Tablets |
90 mg |
Aventis Pharmaceuticals |
Prior to 1/1/1999 |
Unknown |
84 |
CARDIZEM |
Tablets |
120 mg |
Aventis Pharmaceuticals |
Prior to 1/1/1999 |
Unknown |
85 |
CARNITOR |
Oral Solution |
1 gm/10 mL |
Sigma-Tau Pharmaceuticals, Inc. |
04/2005 - 04/2006 |
Unknown |
86 |
CARNITOR |
Tablets |
330 mg |
Sigma-Tau Pharmaceuticals, Inc. |
1/2005 - 12/2005 |
Unknown |
87 |
CECLOR |
Capsules |
eq. 250 mg base |
Eli Lilly and Company |
4/6/2000 |
Unknown |
88 |
CECLOR |
Capsules |
eq. 500 mg base |
Eli Lilly and Company |
4/6/2000 |
Unknown |
89 |
CECLOR |
for Oral Suspension |
eq. 125 mg base/5 mL |
Eli Lilly and Company |
4/18/2000 |
Unknown |
90 |
CECLOR |
for Oral Suspension |
eq. 187 mg base/5 mL |
Eli Lilly and Company |
4/18/2000 |
Unknown |
91 |
CECLOR |
for Oral Suspension |
eq. 250 mg base/5 mL |
Eli Lilly and Company |
4/18/2000 |
Unknown |
92 |
CECLOR |
for Oral Suspension |
eq. 375 mg base/5 mL |
Eli Lilly and Company |
4/18/2000 |
Unknown |
93 |
CEFTIN |
Tablets |
eq. 250 mg base |
GlaxoSmithKline |
12/2002 - 12/2003 |
Unknown |
94 |
CEFTIN |
Tablets |
eq. 500 mg base |
GlaxoSmithKline |
12/2002 - 12/2003 |
Unknown |
95 |
CELEXA |
Tablets |
eq. 10 mg base |
Forest Laboratories, Inc. |
07/2004 - 07/2005 |
Unknown |
96 |
CELEXA |
Tablets |
eq. 20 mg base |
Forest Laboratories, Inc. |
07/2004 - 07/2005 |
Unknown |
97 |
CELEXA |
Tablets |
eq. 40 mg base |
Forest Laboratories, Inc. |
07/2004 - 07/2005 |
Unknown |
98 |
CHILDREN'S MOTRIN |
Suspension |
100 mg/5 mL |
McNeil Consumer Healthcare |
06/1998 - 06/1999 |
Unknown |
99 |
CHILDREN'S MOTRIN (aka INFANT'S MOTRIN) |
Suspension/ Drops |
40 mg/mL |
McNeil Consumer Healthcare |
Prior to 1/1/1999 |
Unknown |
100 |
CILOXAN |
Ophthalmic Solution |
eq. 0.3% base |
Alcon, Inc |
01/2006 - 01/2007 |
Unknown |
101 |
CIPRO |
for Oral Suspension |
250 mg/5 mL |
Bayer Pharmaceuticals Corp. |
06/2003 |
Unknown |
102 |
CIPRO |
for Oral Suspension |
500 mg/5 mL |
Bayer Pharmaceuticals Corp. |
06/2003 |
Unknown |
103 |
CIPRO |
Tablets |
eq. 250 mg base |
Bayer Pharmaceuticals Corp. |
Prior to 1/1/1999 |
Unknown |
104 |
CIPRO |
Tablets |
eq. 500 mg base |
Bayer Pharmaceuticals Corp. |
Prior to 1/1/2000 |
Unknown |
105 |
CIPRO |
Tablets |
eq. 750 mg base |
Bayer Pharmaceuticals Corp. |
Prior to 1/1/2001 |
Unknown |
106 |
CLEOCIN |
Topical Swab |
eq. 1% base |
Pharmacia and Upjohn |
05/2002 - 04/2003 |
Unknown |
107 |
CLEOCIN |
Vaginal Cream |
eq. 2% base |
Pharmacia and Upjohn |
10/2005 - 10/2006 |
Unknown |
108 |
CLEOCIN HCl |
Capsules |
eq. 150 mg base |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
109 |
CLEOCIN HCl |
Capsules |
eq. 300 mg base |
Pharmacia and Upjohn |
03/2001 - 02/2002 |
Unknown |
110 |
CLEOCIN T |
Lotion |
eq. 1% base |
Pharmacia and Upjohn |
03/2003 - 10/2004 |
Unknown |
111 |
CLEOCIN T |
Topical Gel |
eq. 1% base |
Pharmacia and Upjohn |
04/2000 |
Unknown |
112 |
CLEOCIN T |
Topical Solution |
eq. 1% base |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Geneva stopped 05/2000 - 04/2001 |
113 |
CLINORIL |
Tablets |
150 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
114 |
CLINORIL |
Tablets |
200 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
115 |
CLOMID |
Tablets |
50 mg |
Hoechst Marion Roussel, Inc. |
Prior to 1/1/1999 |
Unknown |
116 |
COLESTID |
Tablets |
1 gm |
Pharmacia and Upjohn |
02/2007 |
Unknown |
117 |
COLY-MYCIN M PARENTERAL |
for Injection |
eq 150 mg base/vial |
King Pharmaceuticals Inc. |
06/2006 - 05/2007 |
Unknown |
118 |
COLYTE |
for Oral Solution |
240 gm/bot; 5.84 gm/bot; 2.98 gm/bot; 6.72 gm/bot; 22.72 gm/bot |
Schwarz Pharma, Inc. |
Prior to 1/1/1999 |
Unknown |
119 |
CONDYLOX |
Topical Solution |
0.5% |
Watson Pharma, Inc. |
12/2002 - 12/2003 |
Unknown |
120 |
CORTISPORIN OTIC |
Otic Solution |
eq. 3.5 mg base/g; 10,000 units/g; 1% |
Monarch Pharmaceuticals Inc. |
1/11/1999 |
Unknown |
121 |
CUTIVATE |
Cream |
0.05% |
GlaxoSmithKline Consumer Healthcare |
11/2003 - 11/2004 |
Unknown |
122 |
CUTIVATE |
Ointment |
0.005% |
GlaxoSmithKline Consumer Healthcare |
11/2003 - 11/2004 |
Unknown |
123 |
CYCLESSA |
Tablets |
0.1 mg, 0.125 mg, 0.15 mg; 0.025 mg, 0.025 mg, 0.025 mg |
Organon USA Inc. |
12/2003 - 12/2004 |
Unknown |
124 |
CYTOTEC |
Tablets |
0.1 mg |
GD Searle LLC |
06/2002 - 05/2003 |
Unknown |
125 |
CYTOTEC |
Tablets |
0.2 mg |
GD Searle LLC |
06/2002 - 05/2003 |
Unknown |
126 |
DARVOCET-N 100 |
Tablets |
100 mg/650 mg |
Eli Lilly and Company |
Prior to 1/1/1999 |
Unknown |
127 |
DAYPRO |
Tablets |
600 mg |
GD Searle LLC |
4/4/2001 |
08/2003 - 12/2004 |
128 |
DDAVP |
Nasal Solution |
0.01% |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
129 |
DDAVP |
Nasal Spray |
0.01 mg/spray |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
130 |
DECLOMYCIN |
Tablets |
150 mg |
Stiefel Laboratories, Inc. |
01/2006 - 12/2006 |
Unknown |
131 |
DECLOMYCIN |
Tablets |
300 mg |
Stiefel Laboratories, Inc. |
01/2006 - 12/2006 |
Unknown |
132 |
DEPO-MEDROL |
Injection |
40 mg/mL |
Pharmacia and Upjohn |
05/2006 - 05/2007 |
Unknown |
133 |
DEPO-MEDROL |
Injection |
80 mg/mL |
Pharmacia and Upjohn |
05/2006 - 05/2007 |
Unknown |
134 |
DEPO-PROVERA |
Injection |
150 mg/mL |
Pharmacia and Upjohn |
03/2005 - 03/2006 |
Unknown |
135 |
DERMATOP E EMOLLIENT |
Cream |
0.1% |
Sanofi Aventis US LLC |
10/2006 - 10/2007 |
Unknown |
136 |
DESOGEN |
Tablets |
0.15 mg; 0.03 mg |
Organon USA Inc. |
12/2003 - 12/2004 |
Unknown |
137 |
DIABETA |
Tablets |
1.25 mg |
Hoechst Marion Roussel, Inc. |
05/1998 - 04/1999 |
Unknown |
138 |
DIABETA |
Tablets |
2.5 mg |
Hoechst Marion Roussel, Inc. |
05/1998 - 04/1999 |
Unknown |
139 |
DIABETA |
Tablets |
5 mg |
Hoechst Marion Roussel, Inc. |
05/1998 - 04/1999 |
Unknown |
140 |
DIFLUCAN |
for Oral Suspension |
50 mg/5 mL |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
141 |
DIFLUCAN |
for Oral Suspension |
200 mg/5 mL |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
142 |
DIFLUCAN |
Tablets |
50 mg |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
143 |
DIFLUCAN |
Tablets |
100 mg |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
144 |
DIFLUCAN |
Tablets |
150 mg |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
145 |
DIFLUCAN |
Tablets |
200 mg |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
146 |
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER |
Injection |
200 mg/100 mL |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
147 |
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
Injection |
200 mg/100 mL |
Pfizer Inc. |
11/2004 - 11/2005 |
Unknown |
148 |
DIPROLENE |
Ointment |
eq. 0.05% base |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
149 |
DITROPAN |
Tablets |
5 mg |
Alza Corporation |
Prior to 1/1/1999 |
Unknown |
150 |
DITROPAN XL |
Extended-release Tablets |
5 mg |
Alza Corporation |
12/2004 - 12/2005 |
Unknown |
151 |
DITROPAN XL |
Extended-release Tablets |
10 mg |
Alza Corporation |
12/2004 - 12/2005 |
Unknown |
152 |
DITROPAN XL |
Extended-release Tablets |
15 mg |
Alza Corporation |
12/2005 - 12/2005 |
Unknown |
153 |
DOLOBID |
Tablets |
250 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
154 |
DOLOBID |
Tablets |
500 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
155 |
DOSTINEX |
Tablets |
0.5 mg |
Pharmacia and Upjohn |
12/2004 - 12/2005 |
Unknown |
156 |
DURAGESIC-100 |
Transdermal System |
100 mcg/hr |
Alza Corporation |
06/2004 - 06/2005 |
Unknown |
157 |
DURAGESIC-12 |
Transdermal System |
12 mcg/h |
Alza Corporation |
06/2006 - 06/2007 |
Unknown |
158 |
DURAGESIC-25 |
Transdermal System |
25 mcg/hr |
Alza Corporation |
06/2004 - 06/2005 |
Unknown |
159 |
DURAGESIC-50 |
Transdermal System |
50 mcg/hr |
Alza Corporation |
06/2004 - 06/2005 |
Unknown |
160 |
DURAGESIC-75 |
Transdermal System |
75 mcg/hr |
Alza Corporation |
06/2004 - 06/2005 |
Unknown |
161 |
DYAZIDE |
Capsules |
37.5 mg; 25 mg |
SmithKline Beecham Pharmaceuticals |
Prior to 1/1/1999 |
1/14/1999 |
162 |
ELDEPRYL |
Capsules |
5 mg |
Somerset Pharmaceuticals, Inc. |
05/1998 - 05/1999 |
Unknown |
163 |
ELDEPRYL |
Tablets |
5 mg |
Somerset Pharmaceuticals, Inc. |
06/1999 - 06/2000 |
Unknown |
164 |
ELLENCE |
Injection |
50 mg/25 mL |
Pharmacia and Upjohn |
04/2005 - 04/2006 |
Unknown |
165 |
ELLENCE |
Injection |
200 mg/100 mL |
Pharmacia and Upjohn |
04/2005 - 04/2006 |
Unknown |
166 |
ELOCON |
Cream |
0.1% |
Schering Corporation |
05/2005 - 05/2006 |
Unknown |
167 |
ELOCON |
Topical Solution |
0.1% |
Schering Corporation |
03/2005 - 03/2006 |
Unknown |
168 |
FIORICET WITH CODEINE |
Capsules |
50 mg, 325 mg, 40 mg; 30 mg |
Watson Laboratories, Inc. |
07/2003 - 07/2004 |
Unknown |
169 |
FLAGYL I.V. RTU IN VIAFLEX |
Injection |
500 mg/100 mL |
Baxter Healthcare Corporation |
12/1998 - 12/1999 |
Unknown |
170 |
FLAREX |
Ophthalmic Suspension |
0.10% |
Alcon Laboratories, Inc. |
Prior to 1/1/1999 |
1/2/2004 |
171 |
FLEXERIL |
Tablets |
5 mg |
McNeil Consumer and Specialty Pharmaceuticals |
01/2005 - 01/2006 |
Unknown |
172 |
FLEXERIL |
Tablets |
10 mg |
Merck & Co., Inc. |
Prior to 1/1/1999 |
Unknown |
173 |
FLONASE |
Nasal Spray |
0.05 mg/spray |
Glaxo Wellcome Inc. |
10/1998 - 10/1999 |
Unknown |
174 |
FLORONE |
Cream |
0.05% |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
175 |
FLORONE (aka PSORCON E EMOLLIENT OINTMENT) |
Ointment |
0.05% |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
6/2003 |
176 |
FLUMADINE |
Tablets |
100 mg |
Forest Laboratories, Inc. |
09/2002 - 09/2003 |
Unknown |
177 |
FML |
Ophthalmic Suspension |
0.1% |
Allergan, Inc. |
01/1998 - 01/1999 |
Unknown |
178 |
GARAMYCIN |
Ophthalmic Ointment |
eq. 0.3% base |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
179 |
GARAMYCIN |
Ophthalmic Solution |
eq. 0.3% base |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
180 |
GLUCOPHAGE XR |
Extended-release Tablets |
500 mg |
Bristol Myers Squibb |
10/2002 - 09/2003 |
Unknown |
181 |
GLUCOTROL XL |
Extended-release Tablets |
2.5 mg |
Pfizer Inc. |
07/2004 - 07/2005 |
Unknown |
182 |
GLUCOTROL XL |
Extended-release Tablets |
5 mg |
Pfizer Inc. |
07/2004 - 07/2005 |
Unknown |
183 |
GLUCOTROL XL |
Extended-release Tablets |
10 mg |
Pfizer Inc. |
07/2004 - 07/2005 |
Unknown |
184 |
GLUCOVANCE |
Tablets |
1.25 mg; 250 mg |
Bristol-Myers Squibb Company |
07/2003 - 06/2004 |
Unknown |
185 |
GLUCOVANCE |
Tablets |
2.5 mg; 500 mg |
Bristol-Myers Squibb Company |
07/2003 - 06/2004 |
Unknown |
186 |
GLUCOVANCE |
Tablets |
5 mg; 500 mg |
Bristol-Myers Squibb Company |
07/2003 - 06/2004 |
Unknown |
187 |
GLYNASE |
Tablets |
1.5 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
03/2006 - 03/2007 |
188 |
GLYNASE |
Tablets |
3 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
03/2006 - 03/2007 |
189 |
GLYNASE |
Tablets |
6 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
03/2006 - 03/2007 |
190 |
HALCION |
Tablets |
0.125 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
191 |
HALCION |
Tablets |
0.25 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
192 |
HYTRIN |
Capsules |
eq. 1 mg base |
Abbott Laboratories |
12/2000 - 11/2001 |
prior to 12/2006 |
193 |
HYTRIN |
Capsules |
eq. 2 mg base |
Abbott Laboratories |
12/2000 - 11/2001 |
prior to 12/2006 |
194 |
HYTRIN |
Capsules |
eq. 5 mg base |
Abbott Laboratories |
12/2000 - 11/2001 |
prior to 12/2006 |
195 |
HYTRIN |
Capsules |
eq. 10 mg base |
Abbott Laboratories |
12/2000 - 11/2001 |
prior to 12/2006 |
196 |
IDAMYCIN PFS |
Injection |
1 mg/mL |
Pharmacia and Upjohn |
12/2005 - 12/2006 |
Unknown |
197 |
IMDUR |
Extended-release Tablets |
30 mg |
Schering Corporation |
08/1998 - 08/1999 |
Unknown |
198 |
IMDUR |
Extended-release Tablets |
60 mg |
Schering Corporation |
08/1998 - 08/1999 |
Unknown |
199 |
IMDUR |
Extended-release Tablets |
120 mg |
Schering Corporation |
08/1999 - 08/2000 |
Unknown |
200 |
INDERAL LA |
Extended-release Capsules |
60 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
201 |
INDERAL LA |
Extended-release Capsules |
80 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
202 |
INDERAL LA |
Extended-release Capsules |
120 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
203 |
INDERAL LA |
Extended-release Capsules |
160 mg |
Ayerst Laboratories, Inc. |
04/1999 - 04/2000 |
Unknown |
204 |
INDOCIN |
Capsules |
25 mg |
Merck and Co., Inc. |
06/1998 - 06/1999 |
10/2003 |
205 |
INDOCIN |
Capsules |
50 mg |
Merck and Co., Inc. |
06/1998 - 06/1999 |
10/2003 |
206 |
INDOCIN SR |
Extended-release Capsules |
75 mg |
Merck and Co., Inc. |
Prior to 1/1/1999 |
2/15/01 |
207 |
INSPRA |
Tablets |
25 mg |
GD Searle LLC |
08/2007 - 08/2008 |
Unknown |
208 |
INSPRA |
Tablets |
50 mg |
GD Searle LLC |
08/2007 - 08/2008 |
Unknown |
209 |
K-DUR 10 |
Extended-release Tablets |
10 mEq |
Schering Corporation |
06/2002 - 06/2003 |
Unknown |
210 |
K-DUR 20 |
Extended-release Tablets |
20 mEq |
Schering Corporation |
06/1998 - 06/1999 |
Unknown |
211 |
KEFLEX |
Capsules |
eq. 250 mg base |
Eli Lilly and Company |
Prior to 1/1/1999 |
Unknown |
212 |
KEFLEX |
Capsules |
eq. 500 mg base |
Eli Lilly and Company |
Prior to 1/1/1999 |
Unknown |
213 |
KLARON |
Lotion |
10% |
Sanofi Aventis US LLC |
12/2005 - 12/2006 |
Unknown |
214 |
LAC-HYDRIN |
Cream |
eq. 12% base |
Bristol-Myers Squibb Company |
07/2004 - 06/2005 |
Unknown |
215 |
LAC-HYDRIN |
Lotion |
eq. 12% base |
Bristol-Myers Squibb Company |
03/2004 - 02/2005 |
Unknown |
216 |
LAMICTAL CD |
Tablets for Oral Solution/Susp; Chewable |
5 mg |
GlaxoSmithKline |
5/4/2005 |
06/2006 |
217 |
LAMICTAL CD |
Tablets for Oral Solution/Susp; Chewable |
25 mg |
GlaxoSmithKline |
5/24/2005 |
06/2006 |
218 |
LAMISIL |
Tablets |
eq. 250 mg base |
Novartis Pharmaceuticals Corporation |
05/2007 - 05/2008 |
Unknown |
219 |
LIMBITROL |
Tablets |
5 mg; eq. 12.5 mg base |
Valeant Pharmaceuticals International |
01/2006 - 12/2006 |
Unknown |
220 |
LIMBITROL DS |
Tablets |
10 mg; eq. 25 mg base |
Valeant Pharmaceuticals International |
01/2007 - 12/2007 |
Unknown |
221 |
LIORESAL |
Injection |
0.5 mg/mL |
Medtronic Inc |
06/1999 - 05/2000 |
Unknown |
222 |
LIORESAL |
Injection |
2 mg/mL |
Medtronic Inc |
06/1999 - 05/2000 |
Unknown |
223 |
LODINE |
Capsules |
200 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
224 |
LODINE |
Capsules |
300 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
225 |
LODINE |
Tablets |
400 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
226 |
LODINE |
Tablets |
500 mg |
Ayerst Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
227 |
LODINE XL |
Extended-release Tablets |
400 mg |
Wyeth-Ayerst Laboratories |
09/2000 - 09/2001 |
Unknown |
228 |
LODINE XL |
Extended-release Tablets |
500 mg |
Wyeth-Ayerst Laboratories |
09/2000 - 09/2001 |
Unknown |
229 |
LODINE XL |
Extended-release Tablets |
600 mg |
Wyeth-Ayerst Laboratories |
09/2000 - 09/2001 |
Unknown |
230 |
LOPRESSOR |
Injection |
1 mg/mL |
Novartis Pharmaceuticals Corporation |
03/1998 - 03/1999 |
Unknown |
231 |
LOPROX |
Cream |
0.77% |
Medicis Pharmaceutical Corporation |
12/2004 - 11/2005 |
Unknown |
232 |
LOPROX |
Topical Suspension |
0.77% |
Medicis Pharmaceutical Corporation |
12/2003 - 11/2004 |
Unknown |
233 |
LOTENSIN |
Tablets |
5 mg |
Novartis Pharmaceuticals Corporation |
06/2005 - 06/2006 |
06/2006 - 06/2007 |
234 |
LOTENSIN |
Tablets |
10 mg |
Novartis Pharmaceuticals Corporation |
06/2005 - 06/2006 |
06/2006 - 06/2007 |
235 |
LOTENSIN |
Tablets |
20 mg |
Novartis Pharmaceuticals Corporation |
06/2005 - 06/2006 |
06/2006 - 06/2007 |
236 |
LOTENSIN |
Tablets |
40 mg |
Novartis Pharmaceuticals Corporation |
06/2005 - 06/2006 |
06/2006 - 06/2007 |
237 |
LOTENSIN HCT |
Tablets |
5 mg; 6.25 mg |
Novartis Pharmaceuticals Corporation |
05/2005 - 05/2006 |
Unknown |
238 |
LOTENSIN HCT |
Tablets |
10 mg; 12.5 mg |
Novartis Pharmaceuticals Corporation |
05/2005 - 05/2006 |
Unknown |
239 |
LOTENSIN HCT |
Tablets |
20 mg; 25 mg |
Novartis Pharmaceuticals Corporation |
05/2005 - 05/2006 |
Unknown |
240 |
LOTENSIN HCT |
Tablets |
20 mg; 12.5 mg |
Novartis Pharmaceuticals Corporation |
05/2005 - 05/2006 |
Unknown |
241 |
LOTREL |
Capsules |
eq. 2.5 mg base; 10 mg |
Novartis Pharmaceuticals Corporation |
06/2007 |
Unknown |
242 |
LOTREL |
Capsules |
eq. 5 mg base; 10 mg |
Novartis Pharmaceuticals Corporation |
06/2007 |
Unknown |
243 |
LOTREL |
Capsules |
eq. 5 mg base; 20 mg |
Novartis Pharmaceuticals Corporation |
06/2007 |
Unknown |
244 |
LOTREL |
Capsules |
eq. 10 mg base; 20 mg |
Novartis Pharmaceuticals Corporation |
06/2007 |
Unknown |
245 |
LOTRIMIN |
Cream |
1% |
Schering Corporation |
Prior to 1/1/1999 |
03/2003 - 03/2004 |
246 |
LOTRIMIN AF |
Cream |
1% |
Schering-Plough HealthCare Products, Inc |
03/1998 - 03/1999 |
Unknown |
247 |
LOTRISONE |
Cream |
1%; eq. 0.05% base |
Schering Corporation |
07/2001 - 07/2002 |
Unknown |
248 |
LOTRISONE |
Lotion |
1%; eq. 0.05% base |
Schering Corporation |
12/2004 - 12/2005 |
Unknown |
249 |
LOZOL |
Tablets |
2.5 mg |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
250 |
MACROBID |
Capsules |
75 mg; 25 mg |
Proctor and Gamble Pharmaceuticals, Inc. |
12/2003 - 12/2004 |
Unknown |
251 |
MAXZIDE |
Tablets |
75 mg; 50 mg |
Mylan Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
252 |
MAXZIDE-25 |
Tablets |
37.5 mg; 25 mg |
Mylan Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
253 |
MEDROL |
Tablets |
4 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
254 |
MELLARIL |
Tablets |
10 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
255 |
MELLARIL |
Tablets |
15 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
256 |
MELLARIL |
Tablets |
25 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
257 |
MELLARIL |
Tablets |
50 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
258 |
MELLARIL |
Tablets |
100 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
259 |
MELLARIL |
Tablets |
200 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
260 |
MESNEX |
Injection |
100 mg/mL |
Baxter Healthcare Corporation |
12/2003 - 12/2004 |
Unknown |
261 |
MESTINON |
Tablets |
60 mg |
ICN Pharmaceuticals, Inc. |
04/2002 - 03/2003 |
Unknown |
262 |
METROCREAM |
Cream |
0.75% |
Galderma Laboratories, L.P. |
10/2003 - 09/2004 |
Unknown |
263 |
METROGEL-VAGINAL |
Vaginal Gel |
0.75% |
Graceway Pharmaceuticals, LLC |
08/2006 - 08/2007 |
Unknown |
264 |
MEXITIL |
Capsules |
150 mg |
Boehringer Ingelheim Pharmaceuticals Inc. |
11/1999 - 11/2000 |
11/2004 - 11/2005 |
265 |
MEXITIL |
Capsules |
200 mg |
Boehringer Ingelheim Pharmaceuticals Inc. |
11/1999 - 11/2000 |
11/2004 - 11/2005 |
266 |
MEXITIL |
Capsules |
250 mg |
Boehringer Ingelheim Pharmaceuticals Inc. |
11/1999 - 11/2000 |
11/2004 - 11/2005 |
267 |
MICRONASE |
Tablets |
1.25 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
268 |
MICRONASE |
Tablets |
2.5 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
269 |
MICRONASE |
Tablets |
5 mg |
Pharmacia and Upjohn |
Prior to 1/1/1999 |
Unknown |
270 |
MICRONOR |
Tablets |
0.35 mg |
Ortho-McNeil Pharmaceutical, Inc. |
12/2002 - 11/2003 |
Unknown |
271 |
MICROZIDE |
Capsules |
12.5 mg |
Watson Laboratories, Inc. |
12/1999 - 12/2000 |
Unknown |
272 |
MINOCIN |
Capsules |
eq. 50 mg base |
Lederle Laboratories |
Prior to 1/1/1999 |
9/25/2001 |
273 |
MINOCIN |
Capsules |
eq. 100 mg base |
Lederle Laboratories |
Prior to 1/1/1999 |
9/25/2001 |
274 |
MOBIC |
Oral Suspension |
7.5 mg/5 mL |
Boehringer Ingelheim Pharmaceuticals Inc. |
6/12/2006 |
Unknown |
275 |
MOBIC |
Tablets |
7.5 mg |
Boehringer Ingelheim Pharmaceuticals Inc. |
5/13/2006 |
Unknown |
276 |
MOBIC |
Tablets |
15 mg |
Boehringer Ingelheim Pharmaceuticals Inc. |
5/29/2006 |
Unknown |
277 |
MODURETIC |
Tablets |
eq. 5 mg anhydrous; 50 mg |
Merck and Co., Inc. |
Prior to 1/1/1999 |
Unknown |
278 |
MONODOX |
Capsules |
eq. 50 mg base |
Watson Laboratories, Inc. |
12/2004 - 12/2005 |
Unknown |
279 |
MONODOX |
Capsules |
eq. 100 mg base |
Watson Laboratories, Inc. |
12/2004 - 12/2005 |
Unknown |
280 |
MONOPRIL |
Tablets |
10 mg |
Bristol-Myers Squibb Company |
04/2004 - 03/2005 |
Unknown |
281 |
MONOPRIL |
Tablets |
20 mg |
Bristol-Myers Squibb Company |
04/2004 - 03/2005 |
Unknown |
282 |
MONOPRIL |
Tablets |
40 mg |
Bristol-Myers Squibb Company |
04/2004 - 03/2005 |
Unknown |
283 |
MOTRIN |
Tablets |
400 mg |
McNeil Consumer Healthcare |
Prior to 1/1/1999 |
Unknown |
284 |
MOTRIN |
Tablets |
600 mg |
McNeil Consumer Healthcare |
Prior to 1/1/1999 |
Unknown |
285 |
MOTRIN |
Tablets |
800 mg |
McNeil Consumer Healthcare |
Prior to 1/1/1999 |
Unknown |
286 |
MOTRIN IB (aka MOTRIN MIGRAINE PAIN) |
Tablets |
200 mg |
McNeil Consumer Healthcare |
Prior to 1/1/1999 |
04/2002 |
287 |
MS CONTIN |
Extended-release Tablets |
15 mg |
Purdue Pharma L.P. |
05/2005 - 05/2006 |
Unknown |
288 |
MS CONTIN |
Extended-release Tablets |
30 mg |
Purdue Pharma L.P. |
05/2005 - 05/2006 |
Unknown |
289 |
MS CONTIN |
Extended-release Tablets |
60 mg |
Purdue Pharma L.P. |
05/2005 - 05/2006 |
Unknown |
290 |
MS CONTIN |
Extended-release Tablets |
100 mg |
Purdue Pharma L.P. |
05/2005 - 05/2006 |
Unknown |
291 |
MS CONTIN |
Extended-release Tablets |
200 mg |
Purdue Pharma L.P. |
05/2005 - 05/2006 |
Unknown |
292 |
MYAMBUTOL |
Tablets |
100 mg |
Stat-Trade, Inc. |
11/2006 - 10/2007 |
Unknown |
293 |
MYAMBUTOL |
Tablets |
400 mg |
Stat-Trade, Inc. |
11/2006 - 10/2007 |
Unknown |
294 |
NEBCIN |
Injection |
eq. 10 mg base/mL |
Eli Lilly and Company |
Prior to 1/1/1999 |
Unknown |
295 |
NEURONTIN |
Capsules |
100 mg |
Pfizer Inc. |
08/2004 - 08/2005 |
Unknown |
296 |
NEURONTIN |
Capsules |
300 mg |
Pfizer Inc. |
08/2004 - 08/2005 |
Unknown |
297 |
NEURONTIN |
Capsules |
400 mg |
Pfizer Inc. |
08/2004 - 08/2005 |
Unknown |
298 |
NEURONTIN |
Tablets |
600 mg |
Pfizer Inc. |
08/2004 - 08/2005 |
Unknown |
299 |
NEURONTIN |
Tablets |
800 mg |
Pfizer Inc. |
08/2004 - 08/2005 |
Unknown |
300 |
NICORETTE |
Chewing Gum |
eq. 2 mg base |
GlaxoSmithKline Consumer Healthcare L.P. |
01/2002 - 01/2003 |
Unknown |
301 |
NICORETTE |
Chewing Gum |
eq. 4 mg base |
GlaxoSmithKline Consumer Healthcare L.P. |
06/2001 - 06/2002 |
Unknown |
302 |
NIZORAL |
Shampoo |
2% |
McNeil Consumer and Specialty Pharmaceuticals |
01/2005 - 01/2006 |
Unknown |
303 |
NOLVADEX |
Tablets |
eq. 10 mg base |
Zeneca Pharmaceuticals |
Prior to 1/1/1999 |
12/2002 - 12/2003 |
304 |
NOLVADEX |
Tablets |
eq. 20 mg base |
Zeneca Pharmaceuticals |
Prior to 1/1/1999 |
12/2002 - 12/2003 |
305 |
NORFLEX |
Extended-release Tablets |
100 mg |
3M Pharmaceuticals |
Prior to 1/1/1999 |
Unknown |
306 |
NORMODYNE |
Tablets |
100 mg |
Schering Corporation |
08/1998 - 08/1999 |
Unknown |
307 |
NORMODYNE |
Tablets |
200 mg |
Schering Corporation |
08/1998 - 08/1999 |
Unknown |
308 |
NORMODYNE |
Tablets |
300 mg |
Schering Corporation |
08/1998 - 08/1999 |
Unknown |
309 |
NORPRAMIN |
Tablets |
25 mg |
Aventis Pharmaceutical |
Prior to 1/1/1999 |
Unknown |
310 |
NORPRAMIN |
Tablets |
50 mg |
Aventis Pharmaceutical |
Prior to 1/1/1999 |
Unknown |
311 |
NORPRAMIN |
Tablets |
75 mg |
Aventis Pharmaceutical |
Prior to 1/1/1999 |
Unknown |
312 |
NORPRAMIN |
Tablets |
100 mg |
Aventis Pharmaceutical |
Prior to 1/1/1999 |
Unknown |
313 |
NOR-QD |
Tablets |
0.35 mg |
Watson Laboratories, Inc. |
01/2002 - 01/2003 |
Unknown |
314 |
NORVASC |
Tablets |
eq. 2.5 mg base |
Pfizer Inc. |
4/26/2007 |
Unknown |
315 |
NORVASC |
Tablets |
eq. 5 mg base |
Pfizer Inc. |
4/26/2007 |
Unknown |
316 |
NORVASC |
Tablets |
eq. 10 mg base |
Pfizer Inc. |
4/26/2007 |
Unknown |
317 |
OCUFLOX |
Ophthalmic Solution |
0.3% |
Allergan, Inc. |
07/2004 - 06/2005 |
Unknown |
318 |
OMNICEF |
for Oral Suspension |
125 mg/5 mL |
Abbott Laboratories |
12/2006 - 12/2007 |
Unknown |
319 |
OMNICEF |
for Oral Suspension |
250 mg/5 mL |
Abbott Laboratories |
12/2006 - 12/2007 |
Unknown |
320 |
OPTIPRANOLOL |
Ophthalmic Solution |
0.3% |
Bausch and Lomb Pharmaceuticals |
01/2001 - 12/2001 |
Unknown |
321 |
ORTHO CYCLEN-28 |
Tablets |
0.25 mg; 0.035 mg |
Ortho-McNeil Pharmaceutical, Inc. |
01/2003 |
Unknown |
322 |
ORTHO TRI-CYCLEN |
Tablets |
0.18 mg, 0.215 mg, 0.25 mg; 0.035 mg, 0.035 mg, 0.035 mg |
Ortho-McNeil Pharmaceutical, Inc. |
07/2003 - 06/2004 |
Unknown |
323 |
ORTHO-NOVUM 7/14-28 |
Tablets |
0.5 mg, 1 mg; 0.035 mg, 0.035 mg |
R.W. Johnson Pharmaceutical Research Institute |
04/1998 - 03/1999 |
Unknown |
324 |
ORTHO-NOVUM 7/7/7-28 |
Tablets |
0.5 mg, 0.75 mg, 1 mg; 0.035 mg, 0.035 mg, 0.035 mg |
Ortho-McNeil Pharmaceutical, Inc. |
12/7/2002 |
Unknown |
325 |
ORUVAIL |
Extended-release Capsules |
100 mg |
Wyeth Laboratories |
08/1998 - 09/1999 |
7/10/2002 |
326 |
ORUVAIL |
Extended-release Capsules |
150 mg |
Wyeth Laboratories |
08/1998 - 09/1999 |
7/10/2002 |
327 |
ORUVAIL |
Extended-release Capsules |
200 mg |
Wyeth Laboratories |
08/1998 - 09/1999 |
6/26/2002 |
328 |
OXANDRIN |
Tablets |
2.5 mg |
Savient Pharmaceuticals, Inc. |
06/2006 - 05/2007 |
Unknown |
329 |
OXANDRIN |
Tablets |
10 mg |
Savient Pharmaceuticals, Inc. |
06/2006 - 05/2007 |
Unknown |
330 |
OXYCONTIN |
Extended-release Tablets |
10 mg |
Purdue Pharma L.P. |
09/2004 - 12/2005 |
Unknown |
331 |
OXYCONTIN |
Extended-release Tablets |
20 mg |
Purdue Pharma L.P. |
09/2004 - 12/2005 |
Unknown |
332 |
OXYCONTIN |
Extended-release Tablets |
40 mg |
Purdue Pharma L.P. |
09/2004 - 12/2005 |
Unknown |
333 |
OXYCONTIN |
Extended-release Tablets |
80 mg |
Purdue Pharma L.P. |
09/2004 - 12/2005 |
Unknown |
334 |
PAMINE |
Tablets |
2.5 mg |
Bradley Pharmaceuticals, Inc. |
06/2006 |
Unknown |
335 |
PAMINE FORTE |
Tablets |
5 mg |
Bradley Pharmaceuticals, Inc. |
06/2006 |
Unknown |
336 |
PARAPLATIN |
for Injection |
50 mg/vial |
Bristol-Myers Squibb Company |
03/2004 - 02/2005 |
Unknown |
337 |
PARAPLATIN |
for Injection |
150 mg/vial |
Bristol-Myers Squibb Company |
03/2004 - 02/2005 |
Unknown |
338 |
PARAPLATIN |
for Injection |
450 mg/vial |
Bristol-Myers Squibb Company |
03/2004 - 02/2005 |
Unknown |
339 |
PARAPLATIN AQ |
Injection |
eq. 50 mg/5 mL (10 mg/mL) |
Bristol-Myers Squibb Company |
07/2004 - 06/2005 |
Unknown |
340 |
PARAPLATIN AQ |
Injection |
eq. 150 mg/15 mL (10 mg/mL) |
Bristol-Myers Squibb Company |
07/2004 - 06/2005 |
Unknown |
341 |
PARAPLATIN AQ |
Injection |
eq. 450 mg/45 mL (10 mg/mL) |
Bristol-Myers Squibb Company |
07/2004 - 06/2005 |
Unknown |
342 |
PARAPLATIN AQ |
Injection |
eq. 600 mg/60 mL (10 mg/mL) |
Bristol-Myers Squibb Company |
07/2004 - 06/2005 |
Unknown |
343 |
PARLODEL |
Capsules |
eq. 5 mg base |
Novartis Pharmaceuticals Corporation |
06/1999 - 06/2000 |
Unknown |
344 |
PARLODEL |
Tablets |
eq. 2.5 mg base |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
345 |
PAXIL |
Tablets |
eq. 10 mg base |
GlaxoSmithKline |
11/2002 - 11/2003 |
Unknown |
346 |
PAXIL |
Tablets |
eq. 20 mg base |
GlaxoSmithKline |
11/2002 - 11/2003 |
Unknown |
347 |
PAXIL |
Tablets |
eq. 30 mg base |
GlaxoSmithKline |
11/2002 - 11/2003 |
Unknown |
348 |
PAXIL |
Tablets |
eq. 40 mg base |
GlaxoSmithKline |
11/2002 - 11/2003 |
Unknown |
349 |
PEDIAPRED |
Oral Solution |
eq. 5 mg base/5 mL |
Celltech Pharmaceuticals, Inc. |
05/2001 - 04/2002 |
Unknown |
350 |
PERIOSTAT |
Tablets |
eq. 20 mg base |
CollaGenex Pharmaceuticals, Inc. |
01/2004 - 01/2005 |
06/2007 |
351 |
PHENERGAN |
Tablets |
12.5 mg |
Wyeth Laboratories, Inc. |
Prior to 1/1/1999 |
5/10/2001 |
352 |
PHENERGAN |
Tablets |
25 mg |
Wyeth Laboratories, Inc. |
Prior to 1/1/1999 |
6/4/2001 |
353 |
PHENERGAN |
Tablets |
50 mg |
Wyeth Laboratories, Inc. |
Prior to 1/1/1999 |
6/26/2001 |
354 |
PHENERGAN PLAIN |
Syrup |
6.25 mg/5 mL |
Wyeth Laboratories, Inc. |
Prior to 1/1/1999 |
4/24/2001 |
355 |
PLAQUENIL |
Tablets |
200 mg |
Sanofi-Snythelabo Inc. |
05/1999 - 04/2000 |
Unknown |
356 |
PLETAL |
Tablets |
50 mg |
Otsuka Pharmaceutical Company, Ltd. |
10/18/2004 |
Unknown |
357 |
PLETAL |
Tablets |
100 mg |
Otsuka Pharmaceutical Company, Ltd. |
10/18/2004 |
Unknown |
358 |
PONSTEL |
Capsules |
250 mg |
Sciele Pharma, Inc. |
03/2006 - 03/2007 |
Unknown |
359 |
PRAVACHOL |
Tablets |
10 mg |
Bristol-Myers Squibb Company |
10/2005 - 09/2006 |
Unknown |
360 |
PRAVACHOL |
Tablets |
20 mg |
Bristol-Myers Squibb Company |
10/2005 - 09/2006 |
Unknown |
361 |
PRAVACHOL |
Tablets |
40 mg |
Bristol-Myers Squibb Company |
10/2005 - 09/2006 |
Unknown |
362 |
PRAVACHOL |
Tablets |
80 mg |
Bristol-Myers Squibb Company |
10/2005 - 09/2006 |
Unknown |
363 |
PRILOSEC |
Delayed-release Capsules |
40 mg |
AstraZeneca LP |
04/2008 |
Unknown |
364 |
PROCARDIA XL |
Extended-release Tablets |
30 mg |
Pfizer Inc. |
01/2005 - 01/2006 |
Unknown |
365 |
PROCARDIA XL |
Extended-release Tablets |
60 mg |
Pfizer Inc. |
01/2005 - 01/2006 |
Unknown |
366 |
PROCARDIA XL |
Extended-release Tablets |
90 mg |
Pfizer Inc. |
01/2005 - 01/2006 |
Unknown |
367 |
PROPINE |
Ophthalmic Solution |
0.10% |
Allergan, Inc. |
05/1999 - 04/2000 |
Unknown |
368 |
PROTONIX |
Delayed-release Tablets |
eq. 20 mg base |
Wyeth Pharmaceuticals Inc. |
1/30/2008 |
Unknown |
369 |
PROTONIX |
Delayed-release Tablets |
eq. 40 mg base |
Wyeth Pharmaceuticals Inc. |
1/30/2008 |
Unknown |
370 |
PROVERA |
Tablets |
2.5 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
371 |
PROVERA |
Tablets |
5 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
372 |
PROVERA |
Tablets |
10 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
373 |
PURINETHOL |
Tablets |
50 mg |
Teva Pharmaceuticals USA |
09/2004 - 08/2005 |
Unknown |
374 |
QUINIDEX |
Extended-release Tablets |
300 mg |
A.H. Robins, Inc. |
Prior to 1/1/1999 |
02/2003 - 02/2004 |
375 |
REBETOL |
Capsules |
200 mg |
Schering Corporation |
04/2004 - 06/2005 |
Unknown |
376 |
REGLAN |
Injection |
eq. 5 mg base/mL |
Baxter Healthcare Corporation |
02/2003 - 02/2004 |
Unknown |
377 |
REGLAN |
Tablets |
eq. 10 mg base |
A.H. Robins Company |
Prior to 1/1/1999 |
Unknown |
378 |
REMERON SOLTAB |
Orally Disintegrating Tablets |
15 mg |
Organon USA Inc |
01/2004 - 01/2005 |
Unknown |
379 |
REMERON SOLTAB |
Orally Disintegrating Tablets |
30 mg |
Organon USA Inc |
01/2004 - 01/2005 |
Unknown |
380 |
REMERON SOLTAB |
Orally Disintegrating Tablets |
45 mg |
Organon USA Inc |
01/2004 - 01/2005 |
Unknown |
381 |
RESTORIL |
Capsules |
7.5 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
382 |
RETIN-A |
Cream |
0.025% |
Johnson and Johnson Consumer and Personal Products Worldwide |
09/2004 - 09/2005 |
Unknown |
383 |
RETIN-A |
Cream |
0.05% |
Johnson and Johnson Consumer and Personal Products Worldwide |
07/2004 - 07/2005 |
Unknown |
384 |
RETIN-A |
Cream |
0.1% |
Johnson and Johnson Consumer and Personal Products Worldwide |
01/2005 - 01/2006 |
Unknown |
385 |
RETIN-A |
Gel |
0.01% |
Johnson and Johnson Consumer and Personal Products Worldwide |
10/2004 - 10/2005 |
Unknown |
386 |
RETIN-A |
Gel |
0.025% |
Johnson and Johnson Consumer and Personal Products Worldwide |
04/2005 - 04/2006 |
Unknown |
387 |
RETROVIR |
Tablets |
300 mg |
GlaxoSmithKline |
09/2005 - 09/2006 |
Unknown |
388 |
RITALIN |
Tablets |
5 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
389 |
RITALIN |
Tablets |
10 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
390 |
RITALIN |
Tablets |
20 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
391 |
RITALIN SR |
Extended-release Tablets |
20 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
392 |
ROBINUL |
Injection |
0.2 mg/mL |
Baxter Healthcare Corporation |
02/2004 - 01/2005 |
Unknown |
393 |
ROBINUL |
Tablets |
1 mg |
Sciele Pharma, Inc. |
03/2006 - 03/2007 |
Unknown |
394 |
ROBINUL FORTE |
Tablets |
2 mg |
First Horizon Pharmaceutical Corporation |
03/2005 - 03/2006 |
Unknown |
395 |
ROGAINE (FOR MEN) |
Topical Solution |
2% |
McNeil-PPC, Inc. |
06/1998 - 05/1999 |
Unknown |
396 |
ROGAINE (FOR WOMEN) |
Topical Solution |
2% |
McNeil-PPC, Inc. |
06/1998 - 05/1999 |
Unknown |
397 |
ROGAINE EXTRA STRENGTH (FOR MEN) |
Topical Solution |
5% |
McNeil-PPC, Inc. |
11/2002 - 10/2003 |
Unknown |
398 |
ROWASA |
Rectal Enema |
4 gm/60 mL |
Alaven Pharmaceutical LLC |
12/2006 - 12/2007 |
Unknown |
399 |
SALAGEN |
Tablets |
5 mg |
MGI Pharma, Inc. |
12/2004 |
Unknown |
400 |
SALAGEN |
Tablets |
7.5 mg |
MGI Pharma, Inc. |
03/2006 - 01/2007 |
Unknown |
401 |
SANDOSTATIN |
Injection |
eq. 0.05 mg base/mL |
Novartis Pharmaceuticals Corporation |
10/2004 - 10/2005 |
Unknown |
402 |
SANDOSTATIN |
Injection |
eq. 0.1 mg base/mL |
Novartis Pharmaceuticals Corporation |
10/2004 - 10/2005 |
Unknown |
403 |
SANDOSTATIN |
Injection |
eq. 0.2 mg base/mL |
Novartis Pharmaceuticals Corporation |
10/2004 - 10/2005 |
Unknown |
404 |
SANDOSTATIN |
Injection |
eq. 0.5 mg base/mL |
Novartis Pharmaceuticals Corporation |
10/2004 - 10/2005 |
Unknown |
405 |
SANDOSTATIN |
Injection |
eq. 1 mg base/mL |
Novartis Pharmaceuticals Corporation |
10/2004 - 10/2005 |
Unknown |
406 |
SEASONALE |
Tablets |
0.15 mg; 0.03 mg |
Duramed Pharmaceuticals, Inc. |
9/7/2006 |
Unknown |
407 |
SECTRAL |
Capsules |
eq. 200 mg base |
Wyeth Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
408 |
SECTRAL |
Capsules |
eq. 400 mg base |
Wyeth Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
409 |
SILVADENE |
Cream |
1% |
King Pharmaceuticals, Inc. |
Prior to 1/1/1999 |
Unknown |
410 |
SINEMET |
Tablets |
10 mg; 100 mg |
Bristol-Myers Squibb Company |
05/2001 - 05/2002 |
Unknown |
411 |
SINEMET |
Tablets |
25 mg; 250 mg |
Bristol-Myers Squibb Company |
05/2001 - 05/2002 |
Unknown |
412 |
SINEMET |
Tablets |
25 mg; 100 mg |
Bristol-Myers Squibb Company |
05/2001 - 05/2002 |
Unknown |
413 |
SPORANOX |
Capsules |
100 mg |
Janssen Pharmaceutical Products, L.P. |
2/10/2005 |
Unknown |
414 |
SYMMETREL |
Syrup |
50 mg/5 mL |
Endo Pharmaceuticals Inc. |
Prior to 1/1/1999 |
Unknown |
415 |
TAGAMET |
Tablets |
300 mg |
SmithKline Beecham Pharmaceuticals |
Prior to 1/1/1999 |
6/17/2005 |
416 |
TAGAMET |
Tablets |
400 mg |
SmithKline Beecham Pharmaceuticals |
Prior to 1/1/1999 |
6/17/2005 |
417 |
TAGAMET |
Tablets |
800 mg |
SmithKline Beecham Pharmaceuticals |
Prior to 1/1/1999 |
6/17/2005 |
418 |
TALACEN |
Tablets |
eq. 25 mg base; 650 mg |
Sanofi-Synthelabo Inc |
07/1998 - 09/1999 |
11/3/2000 |
419 |
TAMBOCOR |
Tablets |
50 mg |
3M Pharmaceuticals |
10/2002 |
Unknown |
420 |
TAMBOCOR |
Tablets |
100 mg |
3M Pharmaceuticals |
10/2002 |
Unknown |
421 |
TAMBOCOR |
Tablets |
150 mg |
3M Pharmaceuticals |
10/2002 |
Unknown |
422 |
TENUATE |
Tablets |
25 mg |
Hoechst Marion Roussel, Inc. |
Prior to 1/1/1999 |
Unknown |
423 |
TENUATE DOSPAN |
Extended-release Tablets |
75 mg |
Hoechst Marion Roussel, Inc. |
Prior to 1/1/1999 |
Unknown |
424 |
TERAZOL 3 |
Vaginal Cream |
0.80% |
Ortho-McNeil Pharmaceutical, Inc. |
02/2004 - 01/2005 |
Unknown |
425 |
TERAZOL 7 |
Vaginal Cream |
0.40% |
Ortho-McNeil Pharmaceutical, Inc. |
12/2004 - 11/2005 |
Unknown |
426 |
TESSALON |
Capsules |
100 mg |
Forest Laboratories, Inc. |
Prior to 1/1/1999 |
Unknown |
427 |
TESSALON |
Capsules |
200 mg |
Forest Laboratories, Inc. |
04/1999 - 04/2000 |
Unknown |
428 |
TIAZAC |
Extended-release Capsules |
120 mg |
Biovail Laboratories |
09/2001 - 09/2002 |
Unknown |
429 |
TIAZAC |
Extended-release Capsules |
180 mg |
Biovail Laboratories |
09/2001 - 09/2002 |
Unknown |
430 |
TIAZAC |
Extended-release Capsules |
240 mg |
Biovail Laboratories |
09/2001- 09/2002 |
Unknown |
431 |
TIAZAC |
Extended-release Capsules |
300 mg |
Biovail Laboratories |
09/2001 - 09/2002 |
Unknown |
432 |
TIAZAC |
Extended-release Capsules |
360 mg |
Biovail Laboratories |
09/2001 - 09/2002 |
Unknown |
433 |
TIAZAC |
Extended-release Capsules |
420 mg |
Biovail Laboratories |
09/2006 - 09/2007 |
Unknown |
434 |
TIMOPTIC |
Ophthalmic Solution |
eq, 0.25% base |
Merck and Co., Inc. |
Prior to 1/1/1999 |
8/7/2001 |
435 |
TIMOPTIC |
Ophthalmic Solution |
eq. 0.5% base |
Merck and Co., Inc. |
Prior to 1/1/1999 |
8/7/2001 |
436 |
TOPROL-XL |
Extended-release Tablets |
eq. 25 mg tartrate |
AstraZeneca LP |
08/2006 |
Unknown |
437 |
TOPROL-XL |
Extended-release Tablets |
eq. 50 mg tartrate |
AstraZeneca LP |
09/2007 |
Unknown |
438 |
TOPROL-XL |
Extended-release Tablets |
eq. 100 mg tartrate |
AstraZeneca LP |
09/2007 |
Unknown |
439 |
TOPROL-XL |
Extended-release Tablets |
eq. 200 mg tartrate |
AstraZeneca LP |
08/2007 |
Unknown |
440 |
TORADOL |
Tablets |
10 mg |
Syntex (U.S.A.) Inc. |
Prior to 1/1/1999 |
Unknown |
441 |
TRILAFON |
Tablets |
2 mg |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
442 |
TRILAFON |
Tablets |
4 mg |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
443 |
TRILAFON |
Tablets |
8 mg |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
444 |
TRILAFON |
Tablets |
16 mg |
Schering Corporation |
Prior to 1/1/1999 |
Unknown |
445 |
TRI-NORINYL 28-DAY |
Tablets |
0.5 mg, 1 mg, 0.5 mg; 0.035 mg, 0.035 mg, 0.035 mg |
Watson Laboratories, Inc. |
03/2004 - 03/2005 |
Unknown |
446 |
ULTRACET |
Tablets |
37.5 mg/325 mg |
Ortho-McNeil Pharmaceutical, Inc. |
04/2005 |
Unknown |
447 |
ULTRAVATE |
Cream |
0.05% |
Bristol-Myers Squibb Company |
11/2004 - 10/2005 |
Unknown |
448 |
ULTRAVATE |
Ointment |
0.05% |
Bristol-Myers Squibb Company |
11/2004 - 10/2005 |
Unknown |
449 |
UNITHROID |
Tablets |
0.025 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
450 |
UNITHROID |
Tablets |
0.05 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
451 |
UNITHROID |
Tablets |
0.075 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
452 |
UNITHROID |
Tablets |
0.088 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
453 |
UNITHROID |
Tablets |
0.1 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
454 |
UNITHROID |
Tablets |
0.112 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
455 |
UNITHROID |
Tablets |
0.125 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
456 |
UNITHROID |
Tablets |
0.15 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
457 |
UNITHROID |
Tablets |
0.175 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
458 |
UNITHROID |
Tablets |
0.2 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
459 |
UNITHROID |
Tablets |
0.3 mg |
Jerome Stevens Pharmaceuticals, Inc. |
08/2002 - 07/2003 |
Unknown |
460 |
UNIVASC |
Tablets |
7.5 mg |
Schwarz Pharma, Inc. |
04/2003 - 04/2004 |
Unknown |
461 |
UNIVASC |
Tablets |
15 mg |
Schwarz Pharma, Inc. |
04/2003 - 04/2004 |
Unknown |
462 |
UROCIT-K |
Extended-release Tablets |
5 mEq |
Mission Pharmacal |
11/2007 |
Unknown |
463 |
UROCIT-K |
Extended-release Tablets |
10 mEq |
Mission Pharmacal |
11/2007 |
Unknown |
464 |
VAGISTAT-1 |
Vaginal Ointment |
6.50% |
Bristol-Myers Squibb Company |
02/1998 - 02/1999 |
Unknown |
465 |
VERELAN |
Extended-release Capsules |
120 mg |
Elan Pharmaceutical Research Corporation |
5/17/1999 |
Unknown |
466 |
VERELAN |
Extended-release Capsules |
180 mg |
Elan Pharmaceutical Research Corporation |
5/17/1999 |
Unknown |
467 |
VERELAN |
Extended-release Capsules |
240 mg |
Elan Pharmaceutical Research Corporation |
5/17/1999 |
Unknown |
468 |
VERELAN |
Extended-release Capsules |
360 mg |
Elan Pharmaceutical Research Corporation |
5/17/1999 |
Unknown |
469 |
VERELAN PM |
Extended-release Capsules |
100 mg |
Elan Drug Delivery, Inc. |
11/2006 - 11/2007 |
Unknown |
470 |
VERELAN PM |
Extended-release Capsules |
200 mg |
Elan Drug Delivery, Inc. |
11/2006 - 11/2007 |
Unknown |
471 |
VERELAN PM |
Extended-release Capsules |
300 mg |
Elan Drug Delivery, Inc. |
11/2006 - 11/2007 |
Unknown |
472 |
VIROPTIC |
Ophthalmic Solution |
1% |
Monarch Pharmaceuticals, Inc. |
04/2006 - 03/2007 |
Unknown |
473 |
VOLTAREN |
Delayed-release Tablets |
25 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
474 |
VOLTAREN |
Delayed-release Tablets |
50 mg |
Novartis Pharmaceuticals Corporation |
Prior to 1/1/1999 |
Unknown |
475 |
VOLTAREN XR |
Extended-release Tablets |
100 mg |
Novartis Pharmaceuticals Corporation |
03/2005 - 03/2006 |
Unknown |
476 |
WELLBUTRIN SR |
Extended-release Tablets |
100 mg |
GlaxoSmithKline |
09/2003 - 09/2004 |
Unknown |
477 |
WELLBUTRIN SR |
Extended-release Tablets |
150 mg |
GlaxoSmithKline |
09/2003 - 09/2004 |
Unknown |
478 |
WELLBUTRIN SR |
Extended-release Tablets |
200 mg |
GlaxoSmithKline |
09/2004 - 09/2005 |
Unknown |
479 |
XANAX |
Tablets |
0.25 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
480 |
XANAX |
Tablets |
0.5 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
481 |
XANAX |
Tablets |
1 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
482 |
XANAX |
Tablets |
2 mg |
Pharmacia and Upjohn Company |
Prior to 1/1/1999 |
Unknown |
483 |
XANAX XR |
Extended-release Tablets |
0.5 mg |
Pharmacia and Upjohn |
10/2004 - 10/2005 |
Unknown |
484 |
XANAX XR |
Extended-release Tablets |
1 mg |
Pharmacia and Upjohn |
10/2004 - 10/2005 |
Unknown |
485 |
XANAX XR |
Extended-release Tablets |
2 mg |
Pharmacia and Upjohn |
10/2004 - 10/2005 |
Unknown |
486 |
XANAX XR |
Extended-release Tablets |
3 mg |
Pharmacia and Upjohn |
10/2004 - 10/2005 |
Unknown |
487 |
ZANTAC |
Syrup |
eq. 15 mg base/mL |
GlaxoSmithKline |
3/22/2007 |
Unknown |
488 |
ZAROXOLYN |
Tablets |
2.5 mg |
Celltech Pharmaceuticals, Inc. |
11/2002 - 10/2003 |
Unknown |
489 |
ZAROXOLYN |
Tablets |
5 mg |
Celltech Pharmaceuticals, Inc. |
11/2002 - 10/2003 |
Unknown |
490 |
ZAROXOLYN |
Tablets |
10 mg |
Celltech Pharmaceuticals, Inc. |
11/2002 - 10/2003 |
Unknown |
491 |
ZEBETA |
Tablets |
5 mg |
Lederle Laboratories |
08/2000 - 08/2001 |
Unknown |
492 |
ZEBETA |
Tablets |
10 mg |
Lederle Laboratories |
08/2000 - 08/2001 |
Unknown |
493 |
ZIAC |
Tablets |
2.5 mg; 6.25 mg |
Lederle Laboratories |
07/2000 - 07/2001 |
Unknown |
494 |
ZIAC |
Tablets |
5 mg; 6.25 mg |
Lederle Laboratories |
07/2000 - 07/2001 |
Unknown |
495 |
ZIAC |
Tablets |
10 mg; 6.25 mg |
Lederle Laboratories |
07/2000 - 07/2001 |
Unknown |
496 |
ZITHROMAX |
for Injection |
eq. 500 mg base/vial |
Pfizer Inc. |
03/2006 - 02/2007 |
Unknown |
497 |
ZITHROMAX |
for Oral Suspension |
eq. 1 gm base/packet |
Pfizer Inc. |
03/2006 - 02/2007 |
Unknown |
498 |
ZITHROMAX |
for Oral Suspension |
eq. 100 mg base/5 mL |
Pfizer Inc. |
03/2006 - 02/2007 |
Unknown |
499 |
ZITHROMAX |
for Oral Suspension |
eq. 200 mg base/5 mL |
Pfizer Inc. |
03/2006 - 02/2007 |
Unknown |
500 |
ZITHROMAX |
Tablets |
eq. 250 mg base |
Pfizer Inc. |
03/2006 - 02/2007 |
Unknown |
501 |
ZITHROMAX |
Tablets |
eq. 500 mg base |
Pfizer Inc. |
03/2007 - 02/2008 |
Unknown |
502 |
ZOCOR |
Tablets |
5 mg |
Merck and Co., Inc. |
6/23/2006 |
Unknown |
503 |
ZOCOR |
Tablets |
10 mg |
Merck and Co., Inc. |
6/23/2006 |
Unknown |
504 |
ZOCOR |
Tablets |
20 mg |
Merck and Co., Inc. |
6/23/2006 |
Unknown |
505 |
ZOCOR |
Tablets |
40 mg |
Merck and Co., Inc. |
6/23/2006 |
Unknown |
506 |
ZOCOR |
Tablets |
80 mg |
Merck and Co., Inc. |
6/23/2006 |
Unknown |
507 |
ZOFRAN |
Injection |
eq. 2 mg base/mL |
GlaxoSmithKline |
12/2005 - 12/2006 |
Unknown |
508 |
ZOFRAN |
Oral Solution |
eq. 4 mg base/5 mL |
GlaxoSmithKline |
12/2005 - 12/2006 |
Unknown |
509 |
ZOFRAN |
Tablets |
eq. 4 mg base |
GlaxoSmithKline |
01/1999 - 12/1999 |
Unknown |
510 |
ZOFRAN |
Tablets |
eq. 8 mg base |
GlaxoSmithKline |
01/1999 - 12/1999 |
Unknown |
511 |
ZOFRAN PRESERVATIVE FREE |
Injection |
eq. 2 mg base/mL |
GlaxoSmithKline |
12/2005 - 12/2006 |
Unknown |
512 |
ZOFRAN ODT |
Orally Disintegrating Tablets |
4 mg |
GlaxoSmithKline |
12/2005 - 12/2006 |
Unknown |
513 |
ZOFRAN ODT |
Orally Disintegrating Tablets |
8 mg |
GlaxoSmithKline |
12/2005 - 12/2006 |
Unknown |
514 |
ZOLOFT |
Oral Concentrate |
eq. 20 mg base/mL |
Pfizer Inc. |
05/2006 - 05/2007 |
Unknown |
515 |
ZOLOFT |
Tablets |
eq. 25 mg base |
Pfizer Inc. |
05/2006 - 05/2007 |
Unknown |
516 |
ZOLOFT |
Tablets |
eq. 50 mg base |
Pfizer Inc. |
05/2006 - 05/2007 |
Unknown |
517 |
ZOLOFT |
Tablets |
eq. 100 mg base |
Pfizer Inc. |
05/2006 - 05/2007 |
Unknown |
518 |
ZYBAN |
Extended-release Tablets |
150 mg |
GlaxoSmithKline |
04/2004 - 04/2005 |
Unknown |